Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.5.4.5 extracted from

  • Tibaldi, C.; Camerini, A.; Tiseo, M.; Mazzoni, F.; Barbieri, F.; Vittimberga, I.; Brighenti, M.; Boni, L.; Baldini, E.; Gilli, A.; Honeywell, R.; Chartoire, M.; Peters, G.J.; Giovannetti, E.; Giovannetti, E.
    Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer a prospective validation study (2018), Br. J. Cancer, 119, 1326-1331 .
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine cytidine deaminase as prognostic marker in non-small-cell lung cancer. In the patients with high versus low CDA activity the response rate is 25.0% and 54.1%, the 6-month progression rate is 34.5% and 54.1%, the 1-year survival rate is 23.3% and 57.3%, respectively Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens P32320
-
-

Source Tissue

Source Tissue Comment Organism Textmining
lung
-
Homo sapiens
-
non-small cell lung cancer cell
-
Homo sapiens
-

Synonyms

Synonyms Comment Organism
CDA
-
Homo sapiens